180 related articles for article (PubMed ID: 10298154)
41. Tax Equity's Section 108 restricts provider-based physicians' Medicare reimbursement; hospitals urged to review current contracts.
McCann RW
Health Law Vigil; 1982 Nov; 5(23):2-3. PubMed ID: 10298696
[No Abstract] [Full Text] [Related]
42. Teaming up with administrators to set prospective payment policy.
Shaw LD
Pathologist; 1984 Jun; 38(6):352-3. PubMed ID: 10273529
[TBL] [Abstract][Full Text] [Related]
43. Competition for the health dollar: the pathologist's share.
Olsen HV
Pathologist; 1983 Feb; 37(2):122-4. PubMed ID: 10261175
[TBL] [Abstract][Full Text] [Related]
44. Paying the price. 1983 estimated income from hospital sources.
Penner DW
Pathologist; 1983 Nov; 37(11):818-9. PubMed ID: 10264064
[No Abstract] [Full Text] [Related]
45. The compensation of pathologists.
Johnson JL
Pathologist; 1978 May; 32(5):296-9. PubMed ID: 10307296
[No Abstract] [Full Text] [Related]
46. Medical audit. Putting pathology under the savings spotlight.
Kerr C
Health Soc Serv J; 1985 Dec; 95(4978):1576. PubMed ID: 10317686
[No Abstract] [Full Text] [Related]
47. Acquisition alternatives for capital equipment.
Burrows SB
Pathologist; 1983 May; 37(5):326-8. PubMed ID: 10261179
[TBL] [Abstract][Full Text] [Related]
48. Medicare program; assistants at surgery--Health Care Financing Administration. Final rule.
Fed Regist; 1983 Feb; 48(35):7172-6. PubMed ID: 10298964
[TBL] [Abstract][Full Text] [Related]
49. Medicare: criteria and standards for evaluating intermediary and carrier performance during fiscal year 1989--HCFA. General notice with comment period.
Fed Regist; 1988 Sep; 53(177):35378-83. PubMed ID: 10302820
[TBL] [Abstract][Full Text] [Related]
50. A cost containment checklist.
Garcia LS
MLO Med Lab Obs; 1985 Apr; 17(4):67-8, 71-5. PubMed ID: 10270788
[No Abstract] [Full Text] [Related]
51. How much does an MT program cost the hospital?
Wiebe MF
MLO Med Lab Obs; 1984 Mar; 16(3):105-8, 111. PubMed ID: 10310463
[No Abstract] [Full Text] [Related]
52. Directing the post-TEFRA laboratory.
Sharp JW
Pathologist; 1985 Feb; 39(2):15-8. PubMed ID: 10270443
[TBL] [Abstract][Full Text] [Related]
53. The coming of Medicare--a turbulent time for pathology: Part III.
Coleman FC
Pathologist; 1981 Jun; 35(6):332-6. PubMed ID: 10298195
[No Abstract] [Full Text] [Related]
54. Medicare program; payment for physician services furnished in institutional providers of services--HCFA. Proposed rule.
Fed Regist; 1982 Oct; 47(191):43578-608. PubMed ID: 10299107
[TBL] [Abstract][Full Text] [Related]
55. Hospital finds how to keep pace with new lab technology--without outstripping budget.
Geromini K
Cost Containment; 1982 Feb; 4(3):7. PubMed ID: 10254751
[No Abstract] [Full Text] [Related]
56. Medicare program; indirect Part B payment procedure--HCFA. Final rule.
Fed Regist; 1988 Jul; 53(145):28384-8. PubMed ID: 10302617
[TBL] [Abstract][Full Text] [Related]
57. An on-line cost analysis system.
Whitehouse CR
MLO Med Lab Obs; 1984 Mar; 16(3):115-20. PubMed ID: 10265402
[No Abstract] [Full Text] [Related]
58. Hearings by administrative law judges of certain Medicare claims--HCFA, SSA. General notice.
Fed Regist; 1988 Jun; 53(105):20023-4. PubMed ID: 10302449
[TBL] [Abstract][Full Text] [Related]
59. Pathology practice under TEFRA and DRGs.
Breckenridge RL
Pathologist; 1983 Aug; 37(8):560-2. PubMed ID: 10310298
[TBL] [Abstract][Full Text] [Related]
60. Is that new instrument a winner?
Stafford AC
MLO Med Lab Obs; 1986 Apr; 18(4):24-8. PubMed ID: 10317714
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
